SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced the publication of the first human SPECT images ...
Left: primary/scatter window SPECT reconstructions, plus synthetic and CT-based attenuation maps. Right: SPECT reconstructed images corrected using CT-based attenuation maps, synthetic attenuation ...
To lead the integration and growth of the SPECT business, SHINE has named Michael Rossi as CEO of SHINE SPECT USA, LLC.
MILabs, B.V. the Netherlands‐based innovator and manufacturer of pre‐clinical SPECT/PET/CT imaging devices announces the release of the Plus! Systems: the U‐SPECT + and U‐SPECT + /CT. Both systems ...
Image was selected as “Image of the Month” in the European Journal of Nuclear Medicine and Molecular Imaging, November 2023 SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback